更新M6妊娠部位不明风险预测模型并评估临床因素
这项前瞻性队列研究在8个单位纳入5473例妊娠部位不明(PUL)病例,更新M6模型并评估加入临床因素能否提升性能。更新后M6P模型在EP/PPUL vs IUP/FPUL的AUC为0.89(内部-外部交叉验证)和0.84-0.88(时间外部验证),敏感度分别为94%和92-93%;加入临床因素后部分中心性能改善,尤其当孕酮不适用或不可及时。
要点
- 更新后M6P模型对EP/PPUL vs IUP/FPUL的AUC为0.89(IECV)和0.84-0.88(EV),敏感度94%和92-93%。
- 加入临床因素(母亲年龄、出血评分、EP史)后AUC变化范围为-0.02至0.01(M6P)和-0.01至0.03(M6NP)。
- 在5%高风险阈值下,扩展M6P使敏感度变化-0.02至-0.01、特异度变化0.03至0.04。
核心结论
- 更新后的M6模型对EP具有准确的诊断性能和极好的敏感度;加入临床因素在某些中心改善了性能,尤其当孕酮水平不适用或不可及时。
研究设计与样本
- 前瞻性队列研究,8个单位参与,第一阶段2015年1月至2017年1月连续招募,第二阶段两个中心继续招募至2021年3月;共招募5473例PUL,排除母亲年龄<16岁或初始β-hCG≤25 IU/L的709例后,4764例(87%)纳入分析(第一阶段2894例,第二阶段1870例);常规采集血清检测β-hCG和孕酮,根据经阴道超声和/或随访生化确认分类为FPUL、IUP或EP(包括PPUL);采用内部-外部交叉验证(第一阶段)和时间外部验证(第二阶段),缺失值用多重插补处理。
诊断标准与关键数值
- M6P模型(含孕酮)EP/PPUL vs IUP/FPUL的AUC:IECV为0.89,EV为0.84-0.88;敏感度分别为94%和92-93%。
- M6NP模型(不含孕酮)EP/PPUL vs IUP/FPUL的AUC:IECV为0.85,EV为0.82-0.86;敏感度分别为92%和93-94%。
- 以5%阈值定义EP/PPUL高风险时,扩展M6P使敏感度变化-0.02至-0.01,特异度变化0.03至0.04,Net Benefit变化-0.005至0.006。
- 以5%阈值定义EP/PPUL高风险时,扩展M6NP使敏感度变化-0.03至-0.01,特异度变化0.05至0.07,Net Benefit变化-0.005至0.006。
临床应用与阅片要点
- 更新后的M6模型对EP具有准确的诊断性能和极好的敏感度。
- 加入临床因素(母亲年龄、出血评分和EP史)在某些中心改善了模型性能,尤其当孕酮水平不适用或不可及时。
局限性
- 校准性能总体良好,但中心间存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Ectopic pregnancy (EP) is a major high-risk outcome following a pregnancy of unknown location (PUL) classification. Biochemical markers are used to triage PUL as high vs low risk to guide appropriate follow-up. The M6 model is currently the best risk-prediction model. We aimed to update the M6 model and evaluate whether performance can be improved by including clinical factors.
METHODS: This prospective cohort study recruited consecutive PUL between January 2015 and January 2017 at eight units (Phase 1), with two centers continuing recruitment between January 2017 and March 2021 (Phase 2). Serum samples were collected routinely and sent for β-human chorionic gonadotropin (β-hCG) and progesterone measurement. Clinical factors recorded were maternal age, pain score, bleeding score and history of EP. Based on transvaginal ultrasonography and/or biochemical confirmation during follow-up, PUL were classified subsequently as failed PUL (FPUL), intrauterine pregnancy (IUP) or EP (including persistent PUL (PPUL)). The M6 models with (M6P ) and without (M6NP ) progesterone were refitted and extended with clinical factors. Model validation was performed using internal-external cross-validation (IECV) (Phase 1) and temporal external validation (EV) (Phase 2). Missing values were handled using multiple imputation.
RESULTS: Overall, 5473 PUL were recruited over both phases. A total of 709 PUL were excluded because maternal age was < 16 years or initial β-hCG was ≤ 25 IU/L, leaving 4764 (87%) PUL for analysis (2894 in Phase 1 and 1870 in Phase 2). For the refitted M6P model, the area under the receiver-operating-characteristics curve (AUC) for EP/PPUL vs IUP/FPUL was 0.89 for IECV and 0.84-0.88 for EV, with respective sensitivities of 94% and 92-93%. For the refitted M6NP model, the AUCs were 0.85 for IECV and 0.82-0.86 for EV, with respective sensitivities of 92% and 93-94%. Calibration performance was good overall, but with heterogeneity between centers. Net Benefit confirmed clinical utility. The change in AUC when M6P was extended to include maternal age, bleeding score and history of EP was between -0.02 and 0.01, depending on center and phase. The corresponding change in AUC when M6NP was extended was between -0.01 and 0.03. At the 5% threshold to define high risk of EP/PPUL, extending M6P altered sensitivity by -0.02 to -0.01, specificity by 0.03 to 0.04 and Net Benefit by -0.005 to 0.006. Extending M6NP altered sensitivity by -0.03 to -0.01, specificity by 0.05 to 0.07 and Net Benefit by -0.005 to 0.006.
CONCLUSIONS: The updated M6 model offers accurate diagnostic performance, with excellent sensitivity for EP. Adding clinical factors to the model improved performance in some centers, especially when progesterone levels were not suitable or unavailable. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kyriacou C, Ledger A, Bobdiwala S, et al. Updating M6 pregnancy of unknown location risk-prediction model including evaluation of clinical factors. Ultrasound Obstet Gynecol. 2024. PMID: 37842861. doi:10.1002/uog.27515
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。